Obstructive nephropathy: an update of the experimental research.
Ureteral obstruction (UO) is one of the most common problems confronting the urologist. Although large amounts of animal and clinical research have been done, the pathophysiologic mechanisms accompanying UO are not fully elucidated. Most of our knowledge on UO has been derived from experimental studies in a variety of animal models. Both antenatal and postnatal UO models have been developed mainly by ligation of the ureter or by burying the ureter into the psoas muscle. Most experimental studies have focused on short-term complete ureteral obstruction. The long-term effects of partial ureteral obstruction have been less intensively studied. It is now clear that obstructive nephropathy is not a simple result of mechanical impairment to urine flow but a complex syndrome resulting in alterations of both glomerular hemodynamics and tubular function caused by the interaction of a variety of vasoactive factors and cytokines that are activated in response to UO. Leukocyte infiltration appears to play an important role in obstructive nephropathy suggesting that UO also has an immunological component. Growth factors such as platelet-derived growth factor, transforming growth factor-beta, epidermal growth factor and insulin-like growth factor I may all play a role in the development and progression of fibrotic and sclerotic changes in the obstructed kidney. At present, the selection of patients with congenital hydronephrosis for operative treatment is controversial. Studies in animals and patients have shown that partial unilateral UO does not always cause a loss of renal function or progression in urinary tract dilation during long-term follow-up. The implications of UO continue to raise many questions and further work is necessary to achieve a better understanding of the pathogenesis in obstructive nephropathy.
Wen
J G
JG
Institute of Experimental Clinical Research, University of Aarhus, Denmark.
Frøkiaer
J
J
Jørgensen
T M
TM
Djurhuus
J C
JC
D000818:Animals; D004195:Disease Models, Animal; D006133:Growth Substances / Q000502:physiology; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D012079:Renal Circulation / Q000502:physiology; D014517:Ureteral Obstruction / Q000473:pathology* / Q000503:physiopathology*
D006133:Growth Substances